MedPath

Comparison of the effect of memantine on NSE and GCS among traumatic brain injury patients

Not Applicable
Conditions
Traumatic brain injury.
Intracranial injury
Registration Number
IRCT20100107003014N25
Lead Sponsor
Mazandaran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
60
Inclusion Criteria

Traumatic brain injury (TBI)
Glasgow Coma Scale (GCS) between 6-12
Being at the age of 18 years old and above
The patient can tolerate the drug in the first 24 hours after traumatic brain injury

Exclusion Criteria

Diabetes mellitus, uncontrolled (random blood sugar greater than 200 mg / dL at the time of administration)
Acute myocardial infarction in the last 48 hours
Acute or chronic renal failure, creatinine clearance less than 60 ml per minute
Autoimmune disorders and malignant diseases

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
euron-specific enzyme (NSE). Timepoint: Days 1, 3 and 7. Method of measurement: Laboratory test.;Glasgow coma scale. Timepoint: Days 1, 3 and 7. Method of measurement: clinical.
Secondary Outcome Measures
NameTimeMethod
Survival / Death. Timepoint: 3 months later. Method of measurement: Phone call with patient.
© Copyright 2025. All Rights Reserved by MedPath